Cite
Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02
MLA
Hajime, Orimo, et al. “Effects of Alendronate plus Alfacalcidol in Osteoporosis Patients with a High Risk of Fracture: The Japanese Osteoporosis Intervention Trial (JOINT) - 02.” Current Medical Research and Opinion, vol. 27, no. 6, May 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1cf550ed715f067f44f55bae55386473&authtype=sso&custid=ns315887.
APA
Hajime, O., Toshitaka, N., Masao, F., Hiroaki, O., Takayuki, H., Yukari, U., Tatsuhiko, K., Nobuaki, M., Yasuo, O., Masataka, S., & Kanji, A. (2011). Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02. Current Medical Research and Opinion, 27(6).
Chicago
Hajime, Orimo, Nakamura Toshitaka, Fukunaga Masao, Ohta Hiroaki, Hosoi Takayuki, Uemura Yukari, Kuroda Tatsuhiko, et al. 2011. “Effects of Alendronate plus Alfacalcidol in Osteoporosis Patients with a High Risk of Fracture: The Japanese Osteoporosis Intervention Trial (JOINT) - 02.” Current Medical Research and Opinion 27 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1cf550ed715f067f44f55bae55386473&authtype=sso&custid=ns315887.